RECRUITINGOBSERVATIONAL
Imaging the Pathogenesis of Cerebral Small Vessel Disease
About This Trial
Cerebral small vessel disease (CSVD) can lead to vascular cognitive impairment and dementia (VCID). The hallmark of CSVD is the appearance and progression of white matter hyperintensities (WMH) on MRI. The goal of this study it to recruit and follow individuals at risk for WMH progression and use serial MRI scanning to gain insights into the pathogenesis of CSVD.
Who May Be Eligible (Plain English)
Who May Qualify:
- Clinical or radiographic evidence of ischemic stroke
- One vascular risk factor (hypertension, hyperlipidemia, or diabetes)
- Evidence of cerebral small vessel disease on MRI
Who Should NOT Join This Trial:
- Inability to complete 3 research MRI scans over 1.25 years
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Clinical or radiographic evidence of ischemic stroke
* One vascular risk factor (hypertension, hyperlipidemia, or diabetes)
* Evidence of cerebral small vessel disease on MRI
Exclusion Criteria:
* Inability to complete 3 research MRI scans over 1.25 years
Locations (1)
Kennedy Krieger Institute
Baltimore, Maryland, United States